throbber
Lucian V. Del Priore, MD, PhD, MS, MA (Honorary)
`
`Robert R. Young Professor and Chair
`Department of Ophthalmology
`Yale Eye Center
`40 Temple St., Suite 1B
`New Haven, CT 06510
`Cell 908 625 0395
`ldelpriore@yahoo.com
`
`Robert R. Young Professor and Chair, Department of Ophthalmology and Visual
`Science, Yale Eye Center, Yale University School of Medicine, New Haven, CT, July 2016 to
`present. Chief of Ophthalmology, Yale New Haven Hospital, New Haven, CT, July 2016 to
`present.
`
`Pierre G. Jenkins Professor and Chairman, Department of Ophthalmology,
`Director of the Albert Florens Storm Eye Institute; Professor, Department of Regenerative
`Medicine, Medical University of South Carolina, Charleston, SC, October 2011 to July 2016.
`
`Professor of Clinical Ophthalmology, Department of Ophthalmology and Robert L.
`Burch III Scholar, College of Physicians and Surgeons, Columbia University, New York, NY,
`January 1, 2006 to September 30, 2011; Associate Professor of Ophthalmology and Robert L.
`Burch III Scholar, September 1, 2000 to December 2005. Member, Stem Cell Consortium,
`Columbia University May 2009 – Sept 30, 2011.
`
`Chief of Vitreoretinal Surgery, Associate Professor of Ophthalmology, Associate
`Professor of Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, NJ,
`August 1998 to August 2000.
`
`Assistant Professor of Ophthalmology and Visual Sciences (July 1991 to 1998),
`Assistant Professor of Biochemistry and Molecular Biophysics (July 1991 to 1998),
`Associate Professor of Ophthalmology and Visual Sciences (July 1998 to December 1999),
`Washington University School of Medicine, St. Louis, MO.
`
`Instructor in Ophthalmology, July 1989 to June 1991, The Wilmer Eye Institute, The
`Johns Hopkins Hospital, Baltimore, MD and Attending Ophthalmologist, July 1989 to June
`1991, Washington Eye Physicians and Surgeons, 5454 Wisconsin Avenue, Suite 950, Chevy
`Chase, Maryland 20815.
`
`COMMITTEE EXPERIENCE
`
`Finance Committee, Yale University School of Medicine, July 2016 – present
`
`Medical Executive Committee, Yale New Haven Hospital, July 2016- present
`
`Exhibit 2081
`Page 01 of 58
`
`

`

`Del Priore: curriculum vitae Page 2
`
`Steering Committee, Yale Medicine Access and Care Center, Yale University School of
`Medicine, July 2019-present
`
`Member of the Board, University Medical Associates, Medical University of South
`Carolina, October 2011-2012. Member of the physician practice plan board at MUSC.
`
`Faculty Compensation Committee, Medical University of South Carolina, October
`2011-2012. Committee was responsible for recommending changes in the structure of faculty
`compensation at MUSC.
`
`Access Management Committee, Medical University of South Carolina, October 2012-
`present.
`
`Medical Executive Committee, Medical University of South Carolina, October 2011-
`
`2012.
`
`Practice Plan for Department of Ophthalmology, Physician Representative for
`Clinical Operations, Columbia University College of Physicians and Surgeons, September 2006
`-2010. I worked with the Chairman of the Department for Ophthalmology, departmental
`administrator and the practice manager to restructure departmental clinical operations. I was
`involved in improving efficiency of clinical operations and collections, and all aspects of office,
`including management including patient flow to operations in medical records, photography,
`technicians, front and back office staff.
`
`Executive Committee of the Faculty Council, Columbia University College of
`Physicians and Surgeons, September 2004 to September 2011.
`
`Voting Member of the Faculty Council, Columbia University College of Physicians
`and Surgeons, July 1, 2004 to September 2011.
`
`Clinical Trials Advisory Committee, Columbia University, July 2005 to September
`
`2011.
`
`Board of Directors, Barnes Retina Institute, Barnes Hospital, July 1, 1995 to July 1998.
`Responsible for management of 11 physician joint venture composed of 4 full-time faculty
`members of the Department of Ophthalmology and Visual Sciences at Washington University
`and 7 vitreoretinal surgeons on the part-time staff of Barnes Hospital.
`
`Member, Faculty Compensation Committee, Department of Ophthalmology and
`Visual Sciences, Washington University School of Medicine, February 1995 to January 1997.
`Responsible for restructuring the faculty compensation plan for full-time members of the
`Department of Ophthalmology based on principles of strong faculty incentives in a time of
`decreasing physician reimbursement.
`
`Member, Executive Clinical Faculty, Department of Ophthalmology and Visual
`Sciences, Washington University School of Medicine, 1997-1998.
`
`Exhibit 2081
`Page 02 of 58
`
`

`

`Del Priore: curriculum vitae Page 3
`
`Co-Director, Vitreoretinal Surgery Fellowship Program, Washington University
`School of Medicine, July 1991 to July 1998.
`
`Quality Assurance Subcommittee Member, Barnes Hospital, Fall 1994 to Fall 1996.
`Responsible for quality assurance/outcome analysis within the Department of Ophthalmology.
`
`CLINICAL TRAINING
`
`Fellow in Vitreoretinal Surgery and Assistant Surgeon, 1988 and 1989, Preceptors:
`Ronald G. Michels, MD, Bert M. Glaser, MD, Serge de Bustros, MD; The Wilmer Eye Institute,
`The Johns Hopkins Hospital, Baltimore, MD
`
`Fellow in Glaucoma, 1987 and 1988, Preceptors: Harry A. Quigley, MD, Irv P. Pollack,
`MD; The Wilmer Eye Institute
`
`Resident in Ophthalmology, July 1984 to June 1987, The Wilmer Eye Institute
`
`Intern in Internal Medicine, July 1983 to June 1984, Greater Baltimore Medical Center,
`Baltimore, MD
`
`EDUCATION
`
`MA (M.A. honorary, privatim), February 2017, Yale University, New Haven, CT
`
`PhD in Physics, August 1984, Cornell University, Ithaca, NY. Thesis advisor: Dr. Aaron
`Lewis. The Molecular Basis of Visual Transduction in Vertebrate Rod Photoreceptors.
`
`MD with Distinction in Research, June 1982, The University of Rochester School of
`Medicine and Dentistry, Rochester, NY
`
`MS in Physics, August 1977, Cornell University
`
`BS summa cum laude, June 1975 (Major: Physics; Minor: Mathematics), Cooper Union
`for the Advancement of Science and Art, New York, NY
`
`HOSPITAL PRIVILEGES AND APPOINTMENTS
`
`Attending Ophthalmologist, July 5, 2016 to present, Yale University School of
`Medicine, New Haven, CT
`
`Attending Ophthalmologist, October 1, 2011 to July 2016, Medical University of South
`Carolina, Charleston, SC
`
`Exhibit 2081
`Page 03 of 58
`
`

`

`Del Priore: curriculum vitae Page 4
`
`Attending Ophthalmologist, August 1, 2000 to September 30, 2011, New York
`Presbyterian Hospital, New York, NY
`
`Attending Ophthalmologist, August 1, 1998 to August 1, 2001, University Hospital,
`Newark, NJ
`
`Attending Ophthalmologist, July 1, 1991 to July 1998, Barnes Hospital at Washington
`University Medical Center, Barnes West County Hospital, Saint Louis Children's Hospital, The
`Jewish Hospital of Saint Louis, Veterans Administration Hospital, Saint Louis, MO
`
`Attending Surgeon, July 1989 to June 1991, The Wilmer Eye Institute, The Johns
`Hopkins Hospital, Baltimore, MD and Washington Hospital Center, Washington, D.C.
`
`HONORS AND AWARDS
`
`Inducted into the Retina Hall of Fame, American Society of Retinal Specialists,
`December 2021
`
`New York Ophthalmological Society, inducted at the Union Club, New York, NY,
`April 2019.
`
`Connecticut Magazine Best Doctors, included within a guide published by Castle
`Connolly Medical Limited, Second Edition, 2018-2019.
`
`American Academy of Ophthalmology, Life Fellow and Member, received August
`
`2018
`
`MA (M.A. honorary, privatim), February 2017, Yale University, New Haven, CT
`
`American Academy of Ophthalmology Senior Achievement Award, June 2016.
`Received in recognition of commitment to advancing the profession.
`
`America’s Top Doctors, included within a guide published by Castle Connolly Medical
`Limited, Second Edition, 2002-2019.
`
`Distinguished Alumnus Award, The Wilmer Ophthalmological Institute, June 8, 2012.
`Received in recognition of outstanding contribution to ophthalmology as a Wilmer Graduate.
`
`New York Super Doctors, supplement to the New York Times, 2008, 2009, 2010.
`
`Senior Honor Award, The American Society of Retina Specialists, New York, New
`York September 2009.
`
`Fellow of the Association for Research in Vision and Ophthalmology, ARVO Fellow
`Silver level, inducted in the Class of 2009.
`
`Exhibit 2081
`Page 04 of 58
`
`

`

`New York’s Top Doctors, New York magazine, 2002, 2003, 2004, 2005, 2006, 2007,
`
`2008.
`
`Del Priore: curriculum vitae Page 5
`
`Best Doctors in America, included in 2005-2006 database.
`
`Honor Award, The American Society of Retina Specialists, San Diego, CA 2004.
`
`Honor Award, The Vitreous Society, awarded 2002.
`
`Lew R. Wasserman Award, Research to Prevent Blindness, June 1999
`
`Teacher of the Year Award, Department of Ophthalmology, the University of Medicine
`and Dentistry of New Jersey, June 1999
`
`Honor Award, American Academy of Ophthalmology, awarded 1994
`
`Heed/Knapp Foundation Fellow, July 1988 to June 1989
`
`Heed Foundation Fellow, July 1987 to June 1988
`
`Medical Scientist Training Program Fellow, September 1977 to November 1979, The
`University of Rochester
`
`Biophysics Fellow, September 1976 to August 1977, Cornell University
`
`Sigma Pi Sigma, elected in l974
`
`Board of Regents Scholar, New York State, September 1971 to June 1975
`
`TEACHING EXPERIENCE (non clinical)
`
`Instructor in Bioengineering, January 1980 to August 1980, The University of Utah,
`Salt Lake City, Utah
`
`Teaching Assistant in Physiology, Fall 1979, Cornell University
`
`Lecturer in Physics, Summer 1977 and 1978, Cornell University
`
`Laboratory Instructor in Physics, Summer 1976, Cornell University
`
`Teaching Assistant in Physics, September 1975 to June 1977, Cornell University
`
`PROFESSIONAL MEMBERSHIPS
`American Association for the Advancement of Science
`American Academy of Ophthalmology
`
`Exhibit 2081
`Page 05 of 58
`
`

`

`Del Priore: curriculum vitae Page 6
`
`Association for Research in Vision and Ophthalmology
`American Medical Association
`American Society of Retinal Specialists
`International Society for Eye Research
`The Retina Society
`The Macula Society
`Research to Prevent Blindness
`The European Retina Society of Retina Specialists
`South Carolina Medical Association
`
`BOARD CERTIFICATION
`Diplomate, American Board of Ophthalmology, certified May 16, 1989
`Diplomate, National Board of Medical Examiners, certified November 1984
`
`MEDICAL LICENSURE
`
`STATE
`South Carolina
`New York
`
`New Jersey
`
`Florida
`
`Maryland
`District of Columbia
`Missouri
`Illinois
`
`
`
`LICENSE #
`AL34173
`182408
`
`MA 067450
`ME-0066474
`D34798
`17908
`MD R2P26
`036-092682
`
`
`
`
`STATUS
`ISSUED
`10/18/2011 ACTIVE
`6/26/90
`ACTIVE
`7/1/98
`ACTIVE
`12/9/95
`ACTIVE
`3/3/87
`INACTIVE
`6/28/89
`INACTIVE
`4/26/91
`INACTIVE
`8/1/96
`INACTIVE
`
`MISCELLANOUS LICENSE NUMBERS
`UPIN number
`B 70141
`DEA
`BD 1758785
`NPI
`
`1790702769
`
`PATENTS:
`
`Mark Fields, Huey Cai, Lucian V Del Priore, Denton Hoyer: “Compounds and Methods for
`Treating or Preventing Retinal Degenerations, Including Age-Related Macular Degeneration”
`New U.S. Provisional Patent Application No. 62/614,757 filed January 8, 2018. Yale Ref.: OCR
`7229. Our Ref.: 047162-7149P1(00643)
`
`SCIENTIFIC ADVISORY BOARDS AND FDA PANELS
`
`Consultant - Astellas Institute for Regenerative Medicine, 2017-2021
`
`Scientific advisory board: LambdaVision, Farmington, CT
`
`Scientific advisory board, Tissue Regeneration Sciences, New York, NY
`
`Exhibit 2081
`Page 06 of 58
`
`

`

`Del Priore: curriculum vitae Page 7
`
`Consultant - CavtheRx, New Haven, CT
`
`Medical and Scientific Advisor, Company Co-founder, Seeing Medicines, based out of
`Rochester, MN
`
`Member, FDA Panel September 2017, Ad hoc member for FDA Panel on Ophthalmologic
`Products
`
`Chairman, Regenerative Medicine and Cell Therapy Program (formerly Cell Based Therapy
`Program), July 1, 2005 - forward. Member, Scientific Advisory Board, Foundation Fighting
`Blindness, Owings Mills, Maryland
`
`National Scientific Advisory Council (NSAC) Member, 2012 – forward. American Federation
`for Aging Research (AFAR), 55 West 39th Street, 16th Floor, New York, NY 10018
`
`Scientific Advisory Board, Advanced Cell Technology, Boston, Mass. 2012 – 2016, Responsible
`for overseeing safety aspects of a clinical trial for the treatment of advanced Stargardt’s disease
`with transplantation of stem cells differentiated along an RPE lineage
`
`Member of the International Scientific Committee, August 2007 – 2011, Fondazione Retina 3000
`(medical foundation), Centro Oftalmologico, Milano, Italia
`
`PERSONAL
`Fluent in Italian; can converse in Spanish.
`Hobbies: Tennis, PADI certified scuba diving, snorkeling, skiing.
`
`EDITORIAL BOARDS
`
`1. Journal of Ophthalmology, 2008-forward
`
`2. Journal of Stem Cell Research and Transplantation, Editorial Board Member
`
`3. Open Access Journal of Ophthalmology, MedWin Publishers, Associate Editor
`
`PEER REVIEWER FOR THE FOLLOWING JOURNALS (within last 24 months)
`Nature Medicine
`American Journal of Ophthalmology
`Archives of Ophthalmology
`Current Eye Research
`Experimental Eye Research
`Investigative Ophthalmology and Visual Sciences
`Ophthalmology
`Retina
`
`Exhibit 2081
`Page 07 of 58
`
`

`

`Del Priore: curriculum vitae Page 8
`
`MISCELLANEOUS
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`10.
`
`11.
`
`12.
`
`13.
`
`Moderator, Session on RPE Transplantation, Meeting of the Association for
`Research in Vision and Ophthalmology, Sarasota, FL, May 1994.
`
`Moderator, Session on Submacular Surgery, Meeting of the Association for
`Research in Vision and Ophthalmology, Sarasota, FL, May 1995.
`
`Moderator, ARVO Press Forum on Gene Manipulation/Transplantation in the Eye-
`- A Site for Sore Eyes, Meeting of the Association for Research in Vision and
`Ophthalmology, Fort Lauderdale, FL, May 1997.
`
`Organizer and Member of the Scientific Committee, International Conference on
`New Developments in the Treatment of Age-related Macular Degeneration,
`Gardonne, Italy, June 1997.
`
`Moderator, Platform session on Retinal and RPE Transplantation, Meeting of the
`Association for Research in Vision and Ophthalmology, Sarasota, FL, May 1998.
`
`Member of the National Scientific Advisory Council, American Federation for
`Aging Research, 1414 Avenue of the Americas, New York, NY 10019, November
`1998 to present.
`
`Member of the Program Planning Committee (Retina), Association for Research in
`Vision and Ophthalmology, 1999-2001.
`
`Ad hoc member of the Vision C Study Section, National Institutes of Health,
`Washington DC, October 11-12, 1999.
`
`Ad hoc member of the Vision C Study Section, National Institutes of Health,
`Washington, DC, February 2000.
`
`Moderator, Platform session on Vitreoretinal Experimental Studies, Retina Society
`meeting, Coral Gables, Florida, December 2000.
`
`Moderator, Platform session on Retinal and RPE Transplantation, Meeting of the
`Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May
`2001.
`
`Organizer and Member of the Scientific Committee, Second International
`Conference on New Developments in the Treatment of Age-related Macular
`Degeneration, Gubbio, Italy, June 2001.
`
`Moderator, Platform session on Retinal and RPE Transplantation, Meeting of the
`Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May
`
`Exhibit 2081
`Page 08 of 58
`
`

`

`Del Priore: curriculum vitae Page 9
`
`2002.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`Moderator, Symposium on The Role of Bruch’s Membrane in the Development of
`Age-related Macular Degeneration, Meeting of the Association for Research in
`Vision and Ophthalmology, Ft. Lauderdale, FL, May 2002.
`
`Member, Liaison Committee, Foundation Fighting Blindness Pathophysiology
`facility, December 2002 forward.
`
`Ad hoc member of the Member of Special Emphasis Panel, National Eye Institute,
`EEY1 VSN (01), Bethesda, Maryland, July 26, 2006.
`
`Moderator of Special Interest Group (SIG) Enzymatic Vitreopharmacolysis in
`Vitreoretinal Disease. Association for Research in Vision and Ophthalmology,
`April 2008, Fort Lauderdale, FL.
`
`Moderator, Special Interest Group on Maculoplasty, Association for Research in
`Vision and Ophthalmology, April 2008, Fort Lauderdale, FL.
`
`RESEARCH GRANTS
`
`1. Diabetes Research Training Grant.
`Source: NIH P60 DK20579 Principal Investigator - Dr. David Kipnis.
`From December 1, 1992 to November 30, 1997.
`Role on Project - Consulting Ophthalmologist. 9% effort.
`
`2. Collaborative Ocular Melanoma Study.
`Funding Source: NIH Project # 5 U10 EY06280-11, Principal Investigator/Director - Barbara
`Hawkins, PhD, Chairman- Stuart Fine, MD.
`Annual Direct Costs: $4,900 (Washington University component).
`From: 9/30/85-7/31/00.
`Role: Principal Investigator at Washington University School of Medicine (part of multi-
`centered clinical trial). Percent Effort: <2%.
`
`3. Transplantation of Retinal Pigment Epithelium in Age-related Macular Degeneration.
`Funding Source: The Kemper Foundation, Kansas City, MO.
`Total award: $50,000.
`From: April 1, 1997 to August 1, 1998.
`Role: Principal Investigator.
`
`4. Transplantation of Fetal Porcine Retinal Pigment Epithelium into the Adult Porcine Eye.
`Funding Source: Diacrin Inc
`Total award: $80,000.
`From: December 1, 1997 to August 1, 1998.
`Role: Principal Investigator.
`
`Exhibit 2081
`Page 09 of 58
`
`

`

`Del Priore: curriculum vitae Page 10
`
`5. Individual National Research Service Award.
`Funding Source: National Institutes of Health.
`Total award: $29,004. Effort 9%.
`From: July 1987 to June 1988.
`Role: Post-doctoral Fellow.
`
`6. Transplantation of Pig Retinal Pigment Epithelium
`Funding Source American Federation for Aging Research
`Total award: $25,000.
`From: July 1, 1993 to June 30, 1994.
`Role: Principal Investigator.
`
`7. Laser-Induced Biochemistry of Retinal Pigment Epithelium.
`Funding Source: Diabetes Research Training Center, Washington University.
`Total award: $20,000.
`From: December 1, 1993 to November 30, 1994.
`Role: Principal Investigator.
`
`8. Growth Factor Release after Laser Photocoagulation of the Retinal Pigment Epithelium.
`Funding Source: American Diabetes Association.
`Total award: $100,000.
`From: January 1, 1995 to June 30, 1997.
`Role: Principal Investigator.
`
`9. Binding of Human Retinal Pigment Epithelium to Normal and Diseased Areas of Bruch’s
`Membrane in Organ Culture.
`Funding Source: RP Foundation Fighting Blindness.
`Total award: $240,000.
`From: From January 1, 1996 to December 31, 1998.
`Role: Principal Investigator.
`
`10. Role of Bruch’s Membrane in Age-Related Macular Degeneration.
`Funding Source: New Jersey Fund for the Blind.
`Total award: $2500.
`From: October 1, 1999 to October 1, 2000.
`Role: Principal Investigator.
`
`11. Lew R. Wasserman Award
`Funding Source: Research to Prevent Blindness, New York, NY
`Total award: $55,000.
`From: June 16, 1999 to August 2000.
`Role: Principal Investigator.
`
`12. Transplantation of Retinal Pigment Epithelial Cells May Prevent Atrophy of the
`Choriocapillaris and Overlying Retina. Fight for Sight postdoctoral fellowship award on behalf
`of Dr. Takehiko Suzuki.
`Total award: $14,000.
`
`Exhibit 2081
`Page 10 of 58
`
`

`

`Del Priore: curriculum vitae Page 11
`
`From: July 1, 1999 to June 30, 2000.
`Role: Supervised Postdoctoral Fellow.
`
`13. Postdoctoral Fellowship supplement.
`Funding Source: UMDNJ Foundation
`Total award: $5,000.
`From: July 1, 1999 to June 30, 2000.
`Role: Supervised Postdoctoral Fellow.
`
`14. Binding of Human Retinal Pigment Epithelium to Normal and Diseased Areas of Bruch’s
`Membrane in Organ Culture.
`Source: RP Foundation Fighting Blindness.
`From: July 1, 1999 - June 30, 2001.
`Total award: $194,316.
`Role: Principal Investigator.
`15. Effect of Extracellular Matrix Ligands on RPE Attachment to Bruch’s Membrane
`Funding Source: American Health Assistance Foundation.
`Total award: $137,000
`From: April 1, 1999 to March 30, 2002.
`Role: Principal Investigator.
`
`16. Transplantation of Retinal Pigment Epithelium.
`Source: R01 from the National Eye Institute, National Institute of Health.
`Total award: $411,228.63 (direct costs) for 1/1/94-12/31/96; $600,000 (approximate direct costs)
`for 1/1/97 to12/31/01: Effort: 40%.
`From: January 1, 1994 to December 31, 2001, application in revision.
`Role: Principal Investigator.
`
`17. Xenotransplantation of Fetal Porcine RPE into the Rabbit Eye.
`Funding Source: Diacrin Inc., Charlestown, Massachusetts.
`Total award: $81,543.
`From: February 1, 2001 until December 31, 2002.
`Role: Principal Investigator.
`
`18. Greater NY Center for the Study of Retinal Degeneration: Columbia University Center
`Source: Foundation Fighting Blindness.
`From: July 1, 2001 - June 30, 2005.
`Total award: $1,085,584 for Modules X-XII; $425,627 for module X-XII.
`Role: Director, Columbia University Center
`Principal Investigator for Module X (Binding of Human RPE to Diseased Human
`Bruch’s Membrane in Organ Culture).
`
`19. Changes in Gene Expression of RPE Seeded onto AMD Bruch’s Membrane.
`Funding Source: The Macula Society.
`Total award: $10,000.
`From: January 1, 2002 forward.
`Role: Principal Investigator.
`
`Exhibit 2081
`Page 11 of 58
`
`

`

`Del Priore: curriculum vitae Page 12
`
`20. Unrestricted Funds to Support Eye Research
`Funding Source: Eye Surgery Fund, Columbia University.
`Total award: $140,000.
`From January 1, 2002 to December 2006.
`Role: Principal Investigator.
`
`21. Laser-induced and chemical rejuvenation of aged collagen
`Source: Hickey Family Foundation
`From: March 1, 2005 to February 28, 2008
`Direct Costs: $100,000 per year for 3 years
`Role: Principal Investigator
`Goals: To demonstrate that laser photocoagulation and chemical treatments can be used to
`reverse age-related changes in collagen the human eye, and that this will improve the behavior of
`retinal pigment epithelium in AMD.
`
`22. Stem Cell Transplantation for Retinal Degenerations
`Funding Source: The Macula Foundation
`Total Award: $25,000 per annum for 3 years
`From January 2006-December 2008
`Role: Principal Investigator
`
`23. Greater New York Center for Retinal Degenerative Disease
`Foundation Fighting Blindness, 11435 Cronhill Drive
`Owings Mills, MD 21117-2220
`Role: Principal Investigator, Columbia University component; Co-investigators at Columbia
`University: Rando Allikmets, PhD; Stephen Goff, PhD
`Center Coordinators at other sites:
`Marco A. Zarbin, MD, PhD, University of Medicine and Dentistry of New Jersey
`Ronald Carr, MD; New York University
`Total Amount: $1,683,223
`Dates: 07/01/2005-6/30/2010
`
`24. Embryonic Stem Cell Differentiation in Retinal and RPE Progenitors
`Source: Hickey Family Foundation
`From: March 1, 2008 to February 28, 2011
`Direct Costs: $161,238 for first year; $497,214 total for 3 years
`Role: Principal Investigator
`Goals: To induce the differentiation of embryonic stem cells (mouse and human) into
`photoreceptors and retinal epithelium prior to transplantation into animal models of age-related
`macular degeneration.
`
`25. Generation of a Murine Model of Geographic Atrophy and Its treatment with Embryonic
`Stem Cell Transplantation
`Source: Beckman Institute for Macular Research
`From: July 1, 2010 to June 30, 2011
`Direct Costs: $100,000
`
`Exhibit 2081
`Page 12 of 58
`
`

`

`Role: Principal Investigator. Co-investigators: Stephen Tsang, MD, PhD, Janet Sparrow, PhD, R
`Theodore Smith, MD
`Goals: To generate an animal model of geographic atrophy and treat this disorder with
`embryonic stem cells that are differentiated towards an RPE lineage.
`
`Del Priore: curriculum vitae Page 13
`
`26. Unrestricted Funds to Support Research in Age-related Macular Degeneration
`Funding Source: Robert L. Burch III Fund, Columbia University.
`Total award: $130,000.
`From January 1, 2002 to September 2011.
`Role: Principal Investigator.
`
`27. Greater New York Center for Retinal Degenerative Disease
`Foundation Fighting Blindness, 11435 Cronhill Drive
`Owings Mills, MD 21117-2220
`Role: Principal Investigator
`Total Amount: $1,500,000
`Dates: 07/01/2010-6/30/2015
`
`28. Research to Prevent Blindness
`New York, NY
`Role: Principal Investigator
`Total: $115,000 per year
`Dates: 7/1/11 to 6/30/16
`
`CLINICAL TRIALS:
`
`Second Sight Medical Products, study on implantation of the artificial retina in patient with
`severe retinitis pigmentosa.
`Role: Principal Investigator and Principal Surgeon
`Sponsor: Second Sight
`Purpose: Implanted an artificial retinal prosthesis into the eye of a patient with bare light
`perception vision from end stage retinitis pigmentosa.
`
`PUBLICATIONS
`
`1
`
`2
`
`3
`
`Del Priore LV, Doyle C, Andrade JD. Characterization of Vapor-deposited Silver Films
`Exhibiting Surface-enhanced Raman Scattering by Raman and X-ray Photoelectron
`Spectroscopy. Applied Spectroscopy 36:69-71, 1982.
`Del Priore LV, Lewis A. Calcium-dependent Activation and Deactivation of Rod Outer
`Segment Phosphodiesterase is Calmodulin-independent. Biochem Biophys Res Commun
`113:317- 324, 1983.
`Del Priore LV, Lewis A, Schaat KA. Membrane Structural Alterations in Malignant and
`Normal Avian Lymphocytes: A Raman Investigation. Membrane Biochemistry 5:97-107,
`1984.
`
`Exhibit 2081
`Page 13 of 58
`
`

`

`4
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`21.
`
`22.
`
`23.
`
`Del Priore: curriculum vitae Page 14
`
`Del Priore LV, Lewis A. Vanadate, Tungstate and Molybdate Activate Rod Outer
`Segment Phosphodiesterase in the Dark. Biochem Biophysica Acta 845:81-85, 1985.
`Del Priore LV, Guyton DL. The Jackson Cross Cylinder: A Reappraisal. Ophthalmology
`93:1461-1465, 1986.
`Del Priore LV, Lewis A, Carley WW, Webb WW. Fluorescence Light Microscopy of F-
`Actin in Retinal Rods and Glial Cells. Inv Ophthalmol Vis Sci 8:633-639, 1987.
`Guyton DL, Del Priore LV. Letter to the Editor, The Jackson Cross Cylinder (Reply)
`Ophthalmology 94:893-894, 1987.
`Pollack IP, Robin AL, Streisfeld DL, Del Priore LV, et al. Neodymium:YAG Laser:
`Histopathology of Effects Upon Monkey Trabecular Meshwork and Role in the
`Treatment of Open-angle Glaucoma. In: Glaucoma Update III. Ed: G. K. Krieglstein,
`Springer-Verlag, Berlin Heidelberg (1987), p. 185-193.
`Lewis A, Del Priore LV. The Biophysics of Visual Photoreception. Physics Today 41:38-
`46, 1988.
`Del Priore LV, Robin AL, Pollack IP. Long-term Follow-up of Neodymium:YAG Laser
`Angle Surgery for Open-angle Glaucoma. Ophthalmology 95:277-281, 1988.
`Del Priore LV, Robin AL, Pollack IP. Neodymium:YAG versus Argon Laser Iridotomy
`for Pupillary Block Glaucoma. Ophthalmology 95:1207-1211, 1988.
`Del Priore LV, Glaser BM, Quigley HA, Dorman ME, Green WR. Morphology of Pig
`Retinal Pigment Epithelium Maintained in Organ Culture. Arch Ophthalmology
`106:1286-1290, 1988.
`Del Priore LV, Glaser BM, Quigley HA, Green WR. Response of the Retinal Pigment
`Epithelium to Laser Photocoagulation In Vitro. Arch Ophthalmology l07:119-122, l989.
`Del Priore LV, Michels RG, Nunez MA, Smiddy W, Glaser BM, de Bustros S.
`Intraocular Pressure Measurement after Pars Plana Vitrectomy. Ophthalmology 96:1353-
`1356, 1989.
`Del Priore LV, Miller NR. Trigeminal Schwannoma as a Cause of Chronic Isolated Sixth
`Nerve Palsy. Am J Ophthalmol 108:726-729,1989.
`Schwartz AL, Del Priore LV. The Evolving Role of Argon Laser Trabeculoplasty in
`Glaucoma. Ophthalmology Clinics of North America 4:827-838, 1991.
`Del Priore LV, Kaplan HJ, Silverman MS, Valentino T, Mason G, Hornbeck R.
`Experimental and Surgical Aspects of Retinal Pigment Epithelial Cell Transplantation.
`Eur J Implant Ref Surg 5:128-132, 1993.
`Del Priore LV. Surgical Management of Idiopathic Macular Holes. European Journal of
`Ophthalmology 4:35-42, 1994.
`Bynoe LA, Chang TS, Funata M, Del Priore LV, Kaplan HJ, Green WR. Histopathologic
`Examination of Vascular Patterns in Subfoveal Neovascular Membranes. Ophthalmology
`101:1112-1117, 1994.
`Arfken C, Salicrup A, Meuer S, Del Priore LV, Klein R, J. McGill, Rucker C, White N,
`Santiago J. Retinopathy in African Americans and Whites with Insulin Dependent
`Diabetes Mellitus. Arch Intern Medicine 154:2597-2602, 1994.
`Del Priore LV, Kaplan HJ, Bonham R. Laser Photocoagulation and Fluid-Gas Exchange
`for the Treatment of Recurrent Macular Hole. Retina 14:381-382, 1994.
`De Ungria JM, Del Priore LV, Hart W. Abnormal Disc Vessels after Diabetic
`Papillopathy. Arch Ophthalmol 113:245-246, 1995.
`Desai VN, Del Priore LV, Kaplan HJ. Choriocapillaris Atrophy after Submacular Surgery
`in the Presumed Ocular Histoplasmosis Syndrome. Arch Ophthalmol 113:409-410, 1995.
`
`Exhibit 2081
`Page 14 of 58
`
`

`

`Del Priore: curriculum vitae Page 15
`
`26.
`
`27.
`
`28.
`
`29.
`
`30.
`
`31.
`
`24.
`
`Valentino TL, Kaplan HJ, Del Priore LV, Fang SR, Berger A, Silverman MS. Retinal
`Pigment Epithelial Repopulation in Monkeys after Submacular Surgery. Arch
`Ophthalmol 113:932-938, 1995.
`25. Matsumoto B, Del Priore LV. Transretinal Membrane Formation in Diffuse Unilateral
`Subacute Neuroretinitis. Retina 15:146-149, 1995.
`Del Priore LV, Hornbeck R, Kaplan HJ, Jones Z, Valentino TL, Mosinger-Ogilvie J,
`Swinn M. Debridement of the Pig Retinal Pigment Epithelium In Vivo. Arch Ophthalmol
`113:939-944, 1995.
`Adelberg DA, Del Priore LV, Kaplan HJ. Surgery for Subfoveal Membranes in Myopia,
`Angioid Streaks, and Other Disorders. Retina 15:198-205, 1995.
`Del Priore LV, Kaplan HJ. Pathogenesis of Age-related Macular Degeneration (letter).
`Ophthalmology 102:1125-1126, 1995.
`Akduman LA, Del Priore LV, Kaplan HJ, Meredith TA. Uveal Effusion Syndrome
`Associated with Primary Pulmonary Hypertension and Vomiting. Am J Ophthalmology
`121:578-580, 1996.
`Tezel TH, Del Priore LV. Density-dependent Growth Regulation of Pig Retinal Pigment
`Epithelial Cells In Vitro. Graefe’s Arch Clinical and Experimental Ophthalmology
`234:S89-95, 1996.
`Pollack JS, Del Priore LV, Smith ME, Feiner MA, Kaplan HJ. Postoperative
`Abnormalities of the Choriocapillaris in Exudative Age-related Macular Degeneration.
`Brit J Ophthalmol 80:314-318, 1996.
`Akduman LA, Kolker AE, Black DL, Del Priore LV, Kaplan HJ. Treatment of Persistent
`Glaucoma Secondary to Periocular Corticosteroids. Am J Ophthalmol 122:275-277,
`1996.
`Del Priore LV, Kaplan HJ, Hornbeck R, Jones Z, Swinn M. Retinal Pigment Epithelial
`Debridement as a Model for the Pathogenesis and Treatment of Macular Degeneration.
`Am J Ophthalmol 122:629-643, 1996.
`Tezel TH, Del Priore LV, Flowers BE, Grosof D, Benenson IL, Zamora RL, Kaplan HJ.
`Correlation between Scanning Laser Ophthalmoscope (SLO) Microperimetry and
`Anatomic Abnormalities in Patients with Subfoveal Neovascularization. Ophthalmology
`103:1829-1836, 1996.
`Zamora RL, Del Priore LV, Storch GA, Gelb LD, Sharp J. Multiple Recurrent Branch
`Retinal Artery Occlusions Associated with Varicella Zoster Virus. Retina 16:399-404,
`1996.
`Ho TC, Del Priore LV, Kaplan HJ. En Bloc Transfer of Extracellular Matrix In Vitro.
`Curr Eye Res 15:991-997, 1996.
`Akduman LA, Del Priore LV, Kaplan HJ, Powderly WG. Rifabutin-induced Vitritis in
`AIDS Patients. Ocular Immunology and Inflammation 4:219-224, 1996.
`Ho TC, Del Priore LV, Kaplan HJ. Tissue Culture of Retinal Pigment Epithelium
`Following Isolation with a Gelatin Matrix Technique. Exp Eye Research 64:133-139,
`1997.
`Akduman LA, Desai VN, Del Priore LV, Olk RJ, Kaplan HJ. Visual Improvement After
`Subfoveal Surgery in POHS Depends on Perfusion of Subfoveal Choriocapillaris. Am J
`Ophthalmol 123:90-96,1997.
`Ho TC, Del Priore LV. Reattachment of Human Retinal Pigment Epithelium to
`Extracellular Matrix and Human Bruch’s Membrane. Invest Ophthalmol Vis Sci
`38:1110-1118,1997.
`
`32.
`
`33.
`
`34.
`
`35.
`
`36.
`
`37.
`
`38.
`
`39.
`
`40.
`
`Exhibit 2081
`Page 15 of 58
`
`

`

`41.
`
`42.
`
`43.
`
`44.
`
`45.
`
`46.
`
`47.
`
`48.
`
`49.
`
`50.
`
`51.
`
`52.
`
`53.
`
`54.
`
`55.
`
`56.
`
`57.
`
`Del Priore: curriculum vitae Page 16
`
`Tezel TH, Del Priore LV, Kaplan HJ. Reattachment to a Substrate Prevents Apoptosis of
`Human Retinal Pigment Epithelium. Graefe’s Arch Clin Exp Ophthalmol 235:41-47,
`1997.
`Berman A, Del Priore LV, Fischer CK. Endogenous Ochrobactrum Anthropi
`Endophthalmitis. Am J Ophthalmol 123:560-562, 1997.
`Akduman LA, Adelberg DA, Del Priore LV. Nanophthalmic Uveal Effusion Managed
`with Scleral Windows and Topical Mitomycin-C. Ophthalmic Surgery and Lasers
`28:325-327, 1997.
`Del Priore LV, Kaplan HJ, Berger AS. Retinal Pigment Epithelial Transplantation in the
`Management of Subfoveal Choroidal Neovascularization. Seminars in Ophthalmology
`12:45-55, 1997.
`Ho TC, Del Priore LV, Hornbeck R. Effect of Mitomycin-C on Human Retinal Pigment
`Epithelium in Tissue Culture. Curr Eye Res 16:572-576, 1997.
`Tezel TH, Del Priore LV, Kaplan HJ. Harvest and Storage of Adult Human Reti

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket